TARO Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own TARO shares is N/A, representing N/A of the company's common stock.

BLACKROCK INC., in the last quarter, reduced its stake in TARO by -1.19% restricting it's holding to 615.58 thousand shares of worth nearly $26.06M. MORGAN STANLEY also lessened -0.77% of the TARO shares from its portfolio, reducing its holding to 56 thousand shares of worth $2.37M. BANK OF NEW YORK MELLON CORP also shunned TARO shares holding by -0.69% last quarter which brought its holding to 22.44 thousand shares worth $949.93K.

As per its latest 13F filing, HSBC HOLDINGS PLC increased its stake in TARO by 100% in the last quarter. The institutional holder raised its holding to 95.32 thousand shares having worth more than $4.04M. SQUAREPOINT OPS LLC also added 100% more shares of TARO to its portfolio, raising its holding to 21.66 thousand shares of worth $916.92K. CSS LLC/IL also increased its TARO shares holding by 100% which brought its holding to 20.94 thousand shares worth $886.64K.

The insider with the most stakes in TARO is SUN PHARMACEUTICAL INDUSTRIES LTD , 10 percent owner at the company. Additionally, TARO stock is highly held by 10 percent owner FRANKLIN RESOURCES INC and N/A N/A among others.

Company executives, directors, and other insiders own N/A percent of Taro Pharmaceutical Industries Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which TARO insiders have sold stock, totaling 0 shares. Insiders that have sold shares include FRANKLIN RESOURCES INC.

There have been 0 transaction(s) during the past 6-months in which Taro Pharmaceutical Industries Ltd. insiders have bought stock, totalling 0 shares

Around 0 Taro Pharmaceutical Industries Ltd. shares are held by insiders, which represents about N/A of TARO stock.

TARO 10 percent owner, SUN PHARMACEUTICAL INDUSTRIES LTD holds the largest portfolio of the company's shares. TARO shares owned by SUN total nearly 14.5 million.

HSBC HOLDINGS PLC is the largest institutional owner in TARO which holds 95.32 thousand shares worth $4.04M or 0.25% of the total TARO shares outstanding followed by BLACKROCK INC. with ownership of 615.58 thousand shares representing 1.64% of the TARO ownership. MORGAN STANLEY is the third largest stakeholder with 56 thousand shares or 0.15% of the ownership worth more than $2.37M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the TARO is concerned, it is a stock which is not optionable.

Number of TARO shares short is 73.56K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 37.58M shares of TARO are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, TARO has 8.09M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for TARO is 3.2.